Vivos (RDGL) Research & Development (2010 - 2025)
Vivos (RDGL) reported Research & Development of $57166.0 for Q4 2025, down 43.38% on a YoY basis from $100969.0 in Q4 2024, and down 15.71% sequentially from $67820.0 in Q3 2025.
Vivos (RDGL) Research & Development (2010 - 2025) Analysis & Trends
Vivos (RDGL) has 15 years of Research & Development data on file, last reported at $57166.0 in Q4 2025.
- For the quarter ending Q4 2025, Research & Development fell 43.38% year-over-year to $57166.0; the trailing twelve-month figure through Dec 2025 stood at $352232.0 (up 8.5% YoY), and the FY2025 full-year result was $352232.0, up 8.5% from the prior year.
- Research & Development retreated to $57166.0 in Q4 2025, from $67820.0 in the prior quarter.
- In the past five years, Research & Development ranged from a high of $432112.0 in Q4 2023 to a low of $31736.0 in Q4 2022.
- A 5-year average of $102060.5 and a median of $72134.5 in 2021 frame the typical range for Research & Development.
- Across the five-year window, Research & Development surged 6874.71% in 2021 and sank 76.63% in 2024, its largest moves.
- Tracing RDGL's Research & Development over 5 years: stood at $65694.0 in 2021, then tumbled by 51.69% to $31736.0 in 2022, then soared by 1261.58% to $432112.0 in 2023, then slumped by 76.63% to $100969.0 in 2024, then sank by 43.38% to $57166.0 in 2025.
- Business Quant data shows RDGL's Research & Development at $57166.0 in Q4 2025, $67820.0 in Q3 2025, and $107965.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.44 Bn | 175.14 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 128.91 Bn | 126.03 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 108.67 Bn | 99.45 Bn | 6.41 Bn | 671.00 Mn |
| 4 | Boston Scientific | 68.45 Bn | 67.00 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 47.59 Bn | 43.92 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Dexcom | 28.59 Bn | 27.48 Bn | 750.30 Mn | 145.30 Mn |
| 7 | GE HealthCare Technologies | 28.53 Bn | 26.24 Bn | 1.98 Bn | 345.00 Mn |
| 8 | Smith & Nephew | 26.95 Bn | 26.37 Bn | - | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.30 Bn | 2.07 Bn | -461.27 Mn |
| 10 | Vivos | 27.30 Mn | 25.74 Mn | -3,105.00 | 57,166.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 57,166.00 |
| Sep 30, 2025 | 67,820.00 |
| Jun 30, 2025 | 107,965.00 |
| Mar 31, 2025 | 119,281.00 |
| Dec 31, 2024 | 100,969.00 |
| Sep 30, 2024 | 66,551.00 |
| Jun 30, 2024 | 99,662.00 |
| Mar 31, 2024 | 57,447.00 |
| Dec 31, 2023 | 432,112.00 |
| Sep 30, 2023 | 80,858.00 |
| Jun 30, 2023 | 173,353.00 |
| Mar 31, 2023 | 46,375.00 |
| Dec 31, 2022 | 31,736.00 |
| Sep 30, 2022 | 70,765.00 |
| Jun 30, 2022 | 169,732.00 |
| Mar 31, 2022 | 72,569.00 |
| Dec 31, 2021 | 65,694.00 |
| Sep 30, 2021 | 60,831.00 |
| Jun 30, 2021 | 88,624.00 |
| Mar 31, 2021 | 71,700.00 |